Company / Free Cash Flow
InspireMD, Inc. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$23.3M
FY2025
5-year range
-$23.3M / -$9.2M
FY2021-FY2025
Trend
-38.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow has declined for 4 consecutive years, from -$9M in FY2021 to -$23M in FY2025.
Based on SEC 10-K filings.
-$23M in FY2025.
Declined from -$16M to -$23M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- InspireMD, Inc.'s free cash flow has declined for 4 consecutive years.
- In FY2025, free cash flow decreased 38.9% year-over-year.
- Peak free cash flow was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.42 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$23.3M | -38.9% |
| FY2024 | -$16.8M | -4.6% |
| FY2023 | -$16.0M | -18.2% |
| FY2022 | -$13.6M | -47.8% |
| FY2021 | -$9.2M | +9.2% |
| FY2020 | -$10.1M | -31.6% |
| FY2019 | -$7.7M | +8.5% |
| FY2018 | -$8.4M | -11.2% |
| FY2017 | -$7.5M | +35.0% |
| FY2016 | -$11.6M | +40.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026